GOLDMAN SACHS GROUP INC - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 179 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is 7.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2024$11,125,873
+74.8%
345,524
+110.7%
0.00%
+100.0%
Q1 2024$6,364,539
+0.8%
163,950
-20.0%
0.00%0.0%
Q4 2023$6,311,808
+35.1%
205,062
-1.9%
0.00%0.0%
Q3 2023$4,671,195
+2.1%
209,002
-1.8%
0.00%0.0%
Q2 2023$4,573,438
+62.9%
212,817
+81.8%
0.00%0.0%
Q1 2023$2,807,574
+37.2%
117,031
+32.7%
0.00%0.0%
Q4 2022$2,045,961
+123747.5%
88,188
-14.5%
0.00%
Q3 2022$1,652
+52.5%
103,109
+68.7%
0.00%
Q2 2022$1,083
-99.9%
61,121
-39.4%
0.00%
Q1 2022$2,052,000
-25.8%
100,803
-31.9%
0.00%
-100.0%
Q4 2021$2,767,000
-24.2%
148,120
-19.9%
0.00%0.0%
Q3 2021$3,651,000
-12.9%
184,970
+4.3%
0.00%0.0%
Q2 2021$4,193,000
-6.9%
177,385
-6.6%
0.00%0.0%
Q1 2021$4,503,000
+239.1%
189,997
+186.5%
0.00%
Q4 2020$1,328,000
+41.4%
66,319
+47.0%
0.00%
Q3 2020$939,000
-31.3%
45,126
-42.2%
0.00%
Q2 2020$1,367,000
-36.8%
78,131
-41.0%
0.00%
-100.0%
Q1 2020$2,163,000
-57.3%
132,498
-46.2%
0.00%0.0%
Q4 2019$5,065,000
+444.6%
246,153
+204.0%
0.00%
Q3 2019$930,000
-25.0%
80,980
-14.1%
0.00%
Q2 2019$1,240,000
-54.0%
94,271
-47.1%
0.00%
-100.0%
Q1 2019$2,697,000
-26.0%
178,173
-16.0%
0.00%0.0%
Q4 2018$3,643,000
-25.5%
212,157
-36.1%
0.00%0.0%
Q3 2018$4,891,000
+87.5%
331,785
+203.3%
0.00%0.0%
Q2 2018$2,608,000
+84.4%
109,377
+97.6%
0.00%
Q1 2018$1,414,000
-31.6%
55,353
-50.6%
0.00%
Q4 2017$2,068,000
+87.5%
112,024
+6.5%
0.00%
Q3 2017$1,103,000
+20.3%
105,217
+43.5%
0.00%
Q2 2017$917,000
+0.8%
73,310
-18.9%
0.00%
Q1 2017$910,000
+64.0%
90,377
+153.5%
0.00%
Q4 2016$555,000
+150.0%
35,646
+208.7%
0.00%
Q3 2016$222,000
-57.5%
11,546
-73.8%
0.00%
Q2 2016$522,000
-52.3%
44,088
-26.9%
0.00%
Q1 2016$1,094,000
-2.6%
60,294
+47.7%
0.00%
Q4 2015$1,123,000
+55.8%
40,834
+1.0%
0.00%
Q2 2015$721,00040,4300.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q2 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,887,332$32,405,0008.36%
SECTORAL ASSET MANAGEMENT INC 1,156,934$19,865,0002.70%
1492 Capital Management LLC 150,189$2,579,0002.31%
Eventide Asset Management 2,207,610$37,905,0001.68%
J. Goldman & Co LP 1,066,847$18,318,0001.41%
HAMILTON LANE ADVISORS LLC 89,975$1,545,0001.35%
Rock Springs Capital Management LP 1,605,105$27,560,0001.30%
RICE HALL JAMES & ASSOCIATES, LLC 932,126$16,005,0000.58%
Opaleye Management Inc. 80,000$1,373,0000.51%
Cortina Asset Management, LLC 456,036$7,830,0000.48%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders